Company profile
Alladapt Immunotherapeutics company profile
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being advanced as a broad spectrum oral immunotherapy treatment to mitigate food allergy triggered by single or multiple proteins from an expansive set of common allergens.
Business identity
- Website
- https://www.alladapt.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- New Lisbon, Wisconsin, United States
- Postal code
- 94025
- Country code
- US
- Continent
- North America